Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth L Abramson

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Journal of Cardiovascular Risk|December 13, 2002
Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a reviewBeth L Abramson
Evidence-Based Medicine|January 19, 2013
While hormone therapy unlikely harmful in younger postmenopausal women at low CV risk, protective effects cannot be claimedBeth L Abramson
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 13, 2019
Identifying and managing younger women at high risk of cardiovascular diseaseKajenny Srivaratharajah, Beth L Abramson
Canadian Family Physician Medecin De Famille Canadien|September 13, 2022
Daniel Esau, Beth L Abramson
The Canadian Journal of Cardiology|March 25, 2018
Women and Peripheral Arterial Disease: A Review of Sex Differences in Epidemiology, Clinical Manifestations, and OutcomesKajenny Srivaratharajah, Beth L Abramson
Menopause (New York, N.Y.)|March 20, 2019
Hypertension in menopausal women: the effect and role of estrogenKajenny Srivaratharajah, Beth L Abramson
The Canadian Journal of Cardiology|August 7, 2024
The Challenges of Contemporary Atherosclerotic Cardiovascular Disease ManagementBeth L Abramson, Jean Grégoire
Canadian Family Physician Medecin De Famille Canadien|September 13, 2022
Approach to risk stratification of atherosclerotic cardiovascular disease: Use of biomarkers and imaging in a Canadian contextDaniel Esau, Beth L Abramson
Drugs|September 19, 2006
Cardiovascular health and aromatase inhibitorsKathleen I Pritchard, Beth L Abramson
The Canadian Journal of Cardiology|May 3, 2014
Cardiovascular risk in women: focus on hypertensionBeth L Abramson, Rochelle G Melvin
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Journal of Cardiovascular Risk|December 13, 2002
Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a reviewBeth L Abramson
Evidence-Based Medicine|January 19, 2013
While hormone therapy unlikely harmful in younger postmenopausal women at low CV risk, protective effects cannot be claimedBeth L Abramson
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 13, 2019
Identifying and managing younger women at high risk of cardiovascular diseaseKajenny Srivaratharajah, Beth L Abramson
Canadian Family Physician Medecin De Famille Canadien|September 13, 2022
Daniel Esau, Beth L Abramson
The Canadian Journal of Cardiology|March 25, 2018
Women and Peripheral Arterial Disease: A Review of Sex Differences in Epidemiology, Clinical Manifestations, and OutcomesKajenny Srivaratharajah, Beth L Abramson
Menopause (New York, N.Y.)|March 20, 2019
Hypertension in menopausal women: the effect and role of estrogenKajenny Srivaratharajah, Beth L Abramson
The Canadian Journal of Cardiology|August 7, 2024
The Challenges of Contemporary Atherosclerotic Cardiovascular Disease ManagementBeth L Abramson, Jean Grégoire
Canadian Family Physician Medecin De Famille Canadien|September 13, 2022
Approach to risk stratification of atherosclerotic cardiovascular disease: Use of biomarkers and imaging in a Canadian contextDaniel Esau, Beth L Abramson
Drugs|September 19, 2006
Cardiovascular health and aromatase inhibitorsKathleen I Pritchard, Beth L Abramson
The Canadian Journal of Cardiology|May 3, 2014
Cardiovascular risk in women: focus on hypertensionBeth L Abramson, Rochelle G Melvin
Pageof 6